Fluticasone Furoate, Alone Or In Combination With Vilanterol, Decreases The Rate Of Fev1 Decline In Patients With Moderate Airflow Obstruction: Summit Study

被引：0
|
作者：
Celli, B. R. [1 ]
Martinez, F. J. [2 ]
Anderson, J. [3 ]
Brook, R. [4 ]
Crim, C. [5 ]
Kilbride, S. [3 ]
Newby, D. E. [6 ]
Vestbo, J. [7 ,8 ]
Yates, J. [5 ]
Calverley, P. M. A. [9 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[2] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA
[3] GlaxoSmithKline Res & Dev Ltd, Uxbridge, Middx, England
[4] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[5] GSK, Res Triangle Pk, NC USA
[6] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[7] Univ Manchester, Manchester, Lancs, England
[8] South Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England
[9] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2868
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact Of Vilanterol, Fluticasone Furoate, Or Their Combination On Exacerbations In COPD Patients With Moderate Airflow Obstruction: The Summit Trial
    Martinez, F. J.
    Anderson, J.
    Brook, R.
    Celli, B.
    Crim, C.
    Kilbride, S.
    Newby, D.
    Vestbo, J.
    Yates, J.
    Calverley, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [2] Overview of Safety of Fluticasone Furoate, Vilanterol, or Their Combination in COPD Patients With Moderate Airflow Obstruction: The Summit Trial
    Martinez, Fernando
    Anderson, Julie
    Brook, Robert
    Celli, Bartolome
    Crim, Courtney
    Kilbride, Sally
    Newby, David
    Vestbo, Jorgen
    Yates, Julie
    Calverley, Peter
    CHEST, 2016, 150 (04) : 922A - 922A
  • [3] Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial
    Crim, Courtney
    Calverley, Peter M. A.
    Anderson, Julie A.
    Holmes, Andrew P.
    Kilbride, Sally
    Martinez, Fernando J.
    Brook, Robert D.
    Newby, David E.
    Yates, Julie C.
    Celli, Bartolome R.
    Vestbo, Jorgen
    RESPIRATORY MEDICINE, 2017, 131 : 27 - 34
  • [4] Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction
    Martinez, Fernando J.
    Vestbo, Jorgen
    Anderson, Julie A.
    Brooke, Robert D.
    Celli, Bartolome R.
    Cowans, Nicholas J.
    Crim, Courtney
    Dransfield, Mark
    Kilbride, Sally
    Yates, Julie
    Newby, David E.
    Niewoehner, Dennis
    Calverley, Peter M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (07) : 881 - 888
  • [5] CAPTAIN STUDY: EFFECTS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ON FEV1 IMPROVEMENT IN ASTHMA ACCORDING TO AGE
    Hanania, N.
    Bailes, Z.
    Barnes, N.
    Gardiner, F.
    Lugogo, N.
    Mannino, D.
    Mehta, V.
    Nyanjom, D.
    Sitz, K.
    Kerstjens, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S28 - S28
  • [6] Rate of change of FEV1 and VC in adults with chronic airflow obstruction
    Robson, Andrew
    Innes, Alastair
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [7] Regional differences in rate of FEV1 decline in COPD: lessons from SUMMIT
    Celli, Bartolome R.
    Anderson, Julie A.
    Brook, Robert D.
    Calverley, Peter M. A.
    Cowans, Nicholas J.
    Crim, Courtney
    Martinez, Fernando
    Newby, David E.
    Yates, Julie
    Vestbo, Jorgen
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (06)
  • [8] Reliability of FEV1/FEV6 to Diagnose Airflow Obstruction Compared with FEV1/FVC: The PLATINO Longitudinal Study
    Perez-Padilla, Rogelio
    Wehrmeister, Fernando C.
    Celli, Bartolome R.
    Victorina Lopez-Varela, Maria
    Montes de Oca, Maria
    Muino, Adriana
    Talamo, Carlos
    Jardim, Jose R.
    Valdivia, Gonzalo
    Lisboa, Carmen
    Menezes, Ana Maria B.
    PLOS ONE, 2013, 8 (08):
  • [9] Reliability Of The Diagnosis Of Airflow Obstruction Using The Fev1/fev6 Compared With The Fev1/FVC: The Longitudinal Platino Study
    Perez-Padilla, R.
    Wehrmeister, F.
    Celli, B. R.
    Lopez-Varela, M. V.
    Montes De Oca, M.
    Muino, A.
    Talamo, C.
    Jardim, J. R.
    Valdivia, G.
    Lisboa, C.
    Menezes, A. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [10] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study
    Hu-Yang, Chunshao
    Perez-Fernandez, Virginia
    Andreu Rodriguez, Ada Luz
    Andujar Espinosa, Ruben
    Valverde-Molina, Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (05): : 442 - 443
12345